Regulatory readiness Stat One offers decades of statistical consulting, reporting, and data management experience aimed at FDA submission readiness, presenting an opportunity to upsell end-to-end trial support and regulatory strategy services to biotech firms preparing for regulatory milestones.

Clinical trial focus As a CRO specializing in pharmaceutical, biotechnology, and medical device trials, Stat One can position for expanded engagements such as protocol design, statistical analysis, and data management across therapeutic areas, appealing to mid-stage to late-stage programs seeking expert statistical support.

Mid-market footprint With a small to mid-size employee base and revenue in the 1–10 million range, there is an opportunity to scale partnerships with growing biotech startups and niche firms needing flexible, cost-efficient statistical CRO services without large vendor commitments.

Tech stack synergy Utilize Stat One’s tech footprint (iCIMS, WordPress, Office 365, data and form tools) to propose integrated data workflows, secure communications, and streamlined submission packaging, potentially cross-selling technology-enabled data management and reporting solutions.

Competitive positioning Position Stat One against larger CROs by emphasizing regulatory expertise, efficiency, and customizable engagement models, targeting customers who value hands-on senior statistical oversight and faster time-to-submission in smaller programs.